Sandia Investment Management’s iTeos Therapeutics ITOS Stock Holding History

Sandia Investment Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24,865	Closed	-$248K	–	112
2025 Q2	$248K	Buy	+24,865	New	+$200K	0.64%	54

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sandia Investment Management's ITOS Position: Q3 2025 in Review

Sandia Investment Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 24,865 shares — an estimated $248K sold.

Sandia Investment Management first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $248K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Sandia Investment Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Sandia Investment Management sold 24,865 iTeos Therapeutics shares in Q3 2025, an estimated $248K.
Sandia Investment Management first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Sandia Investment Management's iTeos Therapeutics position peaked at $248K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Sandia Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.